FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483
This webinar is designed to educate businesses in the dietary supplement industry and guide them through the elements of current Good Manufacturing Practices (cGMPs), which have been the focus area of recent FDA inspections. The two-part webinar will provide data on FDA inspections, an overview of emerging compliance issues, and how to respond to an FDA 483 in order to avoid an FDA warning letter. More information.